0000899243-23-017124.txt : 20230706
0000899243-23-017124.hdr.sgml : 20230706
20230706163011
ACCESSION NUMBER: 0000899243-23-017124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230703
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIINBERG ULF
CENTRAL INDEX KEY: 0001187314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 231073968
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-03
0
0001098972
AGENUS INC
AGEN
0001187314
WIINBERG ULF
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
1
0
0
0
0
Deferred Stock Units
2023-07-03
4
A
0
16018.322
A
Common Stock
16018.322
191528.442
D
Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
$1.60 per Deferred Stock Unit acquired on July 3, 2023. The price of each Deferred Stock Unit acquired on July 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.
/s/Christine Klaskin, as Attorney-in-Fact for Ulf Wiinberg
2023-07-06